TITLE:
Antabuse for Lyme Disease: The Way Forward
AUTHORS:
David S. Younger, Beverley F. Murphy
KEYWORDS:
Disulfiram, Antabuse, Lyme Disease, Immune Globulin Therapy
JOURNAL NAME:
World Journal of Neuroscience,
Vol.10 No.1,
November
29,
2019
ABSTRACT: Despite leadership by dedicated lay organization and patient-based advocacy groups, the way forward for prospective candidates for disulfiram treatment has been difficult. This article provides the background, overview of disulfiram, in particular its intended use in post-treatment Lyme disease syndrome after a standard of care course of antibiotics fails to alleviate symptoms of tick borne disease. A series of recommendations are offered to guide patients and clinicians.